PT  - JOURNAL ARTICLE
AU  - Wan Nor Arifin
AU  - Kamarul Imran Musa
AU  - Tengku Muhammad Hanis
AU  - Wan Shakira Rodzlan Hasani
AU  - Che Muhammad Nur Hidayat Che Nawi
AU  - Erwan Ershad Ahmad Khan
AU  - Mohd Azmi Suliman
AU  - Sahrol Azmi Termizi
AU  - Wira Alfatah Ab Aziz
AU  - on behalf of the USM Epidemiological Modelling Team
TI  - A brief analysis of the COVID-19 death data in Malaysia
AID  - 10.1101/2021.09.28.21264234
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.09.28.21264234
4099  - http://medrxiv.org/content/early/2021/09/29/2021.09.28.21264234.short
4100  - http://medrxiv.org/content/early/2021/09/29/2021.09.28.21264234.full
AB  - In December 2019, the first cases of Coronavirus Disease 2019 (COVID-19) were detected in Wuhan, China. Since then, COVID-19 begun to spread rapidly all over the world. On March 11, 2020, the World Health Organisation declared COVID-19 a pandemic. As of September 7, 2021, there were over 220 million confirmed COVID-19 cases globally, with more than 4.6 million deaths. Malaysia reported 2,067,327 confirmed cases with 22,743 deaths. Given the severity of the pandemic, the Ministry of Health Malaysia has stepped up in its efforts in handling the pandemic locally by sharing the COVID-19 related data on the GitHub, enabling transparent data sharing. This enables timely data analysis and quick decision to better understand the COVID-19 situation in this country. This article aims to provide a quick analysis of the death and vaccination data provided by the Malaysian Ministry of Health and to provide useful insight into the analysis.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors received no funding for the work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicable.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used in the article are publicly available. https://github.com/MoH-Malaysia/covid19-public https://github.com/CITF-Malaysia/citf-public